【结 构 式】 |
【药物名称】Idarubicin hydrochloride, NSC-256439, IMI-30, DMDR, Idamycin, Zavedos 【化学名称】(1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride 【CA登记号】58957-92-9 【 分 子 式 】C26H28ClNO9 【 分 子 量 】533.96736 |
【开发单位】Pfizer (Originator) 【药理作用】Oncolytic Drugs, Anthracyclines |
合成路线1
The condensation of chiral tetraline (I) with phthalic anhydride (II) by means of AlCl3 at 180 C gives the naphthacenedione (III), which is ketalized at the acetyl group with ethylene glycol and p-toluenesulfonic acid yielding the dioxolane (IV). The hydroxylation of (IV) with Br2 and AIBN in CCl4/CHCl3 affords the 4-demethoxy-7-epidaunomycinone (V), which is isomerized with TFA yielding 4-demethoxydaunomycinone (VI) . The condensation of (VI) with the acylated hexopyranosyl chloride (VII) by means of CF3SO3Ag of Br2Hg affords the trifluoroacetylated 4-demethoxydaunomycin (VIII), which is finally treated with NaOH in order to eliminate the trifluoroacetyl groups
【1】 Arcamone, F.; et al.; Synthesis and antitumour activity of new daunorubicin and adriamycin analogues. Experientia 1978, 34, 1255. |
【2】 Bernardi, L.; Arcamone, F.; Patelli, B.; Di Marco, A. (Pharmacia Corp.); Daunomycin analogues, their preparation and use. DE 2525633; US 4046878 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
11295 | Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol | 107-21-1 | C2H6O2 | 详情 | 详情 | |
(I) | 34606 | 1-[(2R)-2-hydroxy-5,8-dimethoxy-1,2,3,4-tetrahydro-2-naphthalenyl]-1-ethanone | C14H18O4 | 详情 | 详情 | |
(II) | 11900 | 2-Benzofuran-1,3-dione;1,2-Benzenedicarboxylic Anhydride;1,2-BENZENE DICARBOXYLIC ACID ANHYDRIDE;1,2-BENZENEDICARBONIC ACID, ANHYDRIDE;1,3-DIOXOPHTHALAN;1,3-ISOBENZOFURANDIONE;o-phthalic anhydride; Phthalic anhydride | 85-44-9 | C8H4O3 | 详情 | 详情 |
(III) | 34607 | (8R)-8-acetyl-6,8,11-trihydroxy-7,8,9,10-tetrahydro-5,12-naphthacenedione | C20H16O6 | 详情 | 详情 | |
(IV) | 34608 | (8R)-6,8,11-trihydroxy-8-(2-methyl-1,3-dioxolan-2-yl)-7,8,9,10-tetrahydro-5,12-naphthacenedione | C22H20O7 | 详情 | 详情 | |
(V) | 34609 | (2S,4R)-2-acetyl-2,4,5,12-tetrahydroxy-3,4-dihydro-1,6,11(2H)-naphthacenetrione | C20H14O8 | 详情 | 详情 | |
(VI) | 34610 | (2S,4S)-2-acetyl-2,4,5,12-tetrahydroxy-3,4-dihydro-1,6,11(2H)-naphthacenetrione | C20H14O8 | 详情 | 详情 | |
(VII) | 34611 | (2S,3S,4S,6S)-6-chloro-2-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydro-2H-pyran-3-yl 2,2,2-trifluoroacetate | C10H10ClF6NO4 | 详情 | 详情 | |
(VIII) | 34612 | (3S,4S,6R)-6-[[(1S,3S)-3-acetyl-3,5,12-trihydroxy-4,6,11-trioxo-1,2,3,4,6,11-hexahydro-1-naphthacenyl]oxy]-2-methyl-4-[(2,2,2-trifluoroacetyl)amino]tetrahydro-2H-pyran-3-yl 2,2,2-trifluoroacetate | C30H23F6NO12 | 详情 | 详情 |
合成路线2
The reaction of daunomycinone (IX) with AlCl3 in dichloromethane gives 4-demethyldaunomycinone (X), which is ketalized with ethylene glycol as before yielding the dioxolane (XI). The selective sulfonation of (XI) with TsCl, DIEA and DMAP in pyridine affords the 4-tosyloxy derivative (XII), which is treated with 4-methoxybenzylamine (XIII) in pyridine providing the secondary benzylamine (XIV). Elimination of the benzyl protecting group of (XIV) with TFA gives 4-amino-4-demethoxydaunomycinone ethylene ketal (XV), which is deaminated by reaction with TFA, NaNO2 and H3PO2 to give 4-demethoxydaunomycinone (XVI). Finally, this compound is submitted to fermentation with Streptomyces peucetius corneus, S. Peucetius caesius, S. Caeruleus, S. Peucetius, S. Coeruleorubidus, and other chemical or radio-induced mutants thereof.
【1】 Francalanci, F.; Martinengo, T.; de Bernardinis, S.; Cabri, W. (Pharmacia Corp.); Process for the preparation of 4-demethoxydaunomycinone, the aglycone of 4-demethoxy-daunorubicin. EP 0328399 . |
【2】 Mitscher, L.A.; Lednicer, D. (Pharmacia Corp.); Biosynthesis of simplified anthracyclines. US 4471052 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
11295 | Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol | 107-21-1 | C2H6O2 | 详情 | 详情 | |
(IX) | 34613 | (2S,4S)-2-acetyl-2,4,5,12-tetrahydroxy-7-methoxy-3,4-dihydro-1,6,11(2H)-naphthacenetrione | C21H16O9 | 详情 | 详情 | |
(X) | 34614 | (2S,4S)-2-acetyl-2,4,5,7,12-pentahydroxy-3,4-dihydro-1,6,11(2H)-naphthacenetrione | C20H14O9 | 详情 | 详情 | |
(XI) | 34615 | (2R,4S)-2,4,5,7,12-pentahydroxy-2-(2-methyl-1,3-dioxolan-2-yl)-3,4-dihydro-1,6,11(2H)-naphthacenetrione | C22H18O10 | 详情 | 详情 | |
(XII) | 34616 | (8R,10S)-6,8,10,11-tetrahydroxy-8-(2-methyl-1,3-dioxolan-2-yl)-5,7,12-trioxo-5,7,8,9,10,12-hexahydro-1-naphthacenyl 4-methylbenzenesulfonate | C29H24O12S | 详情 | 详情 | |
(XIII) | 15098 | 4-Methoxybenzylamine; (4-Methoxyphenyl)methanamine | 2393-23-9 | C8H11NO | 详情 | 详情 |
(XIV) | 34617 | (2R,4S)-2,4,5,12-tetrahydroxy-7-[(4-methoxybenzyl)amino]-2-(2-methyl-1,3-dioxolan-2-yl)-3,4-dihydro-1,6,11(2H)-naphthacenetrione | C30H27NO10 | 详情 | 详情 | |
(XV) | 34618 | (2R,4S)-7-amino-2,4,5,12-tetrahydroxy-2-(2-methyl-1,3-dioxolan-2-yl)-3,4-dihydro-1,6,11(2H)-naphthacenetrione | C22H19NO9 | 详情 | 详情 | |
(XVI) | 34610 | (2S,4S)-2-acetyl-2,4,5,12-tetrahydroxy-3,4-dihydro-1,6,11(2H)-naphthacenetrione | C20H14O8 | 详情 | 详情 |